Physician profile
Kellie Lynn Kopp
NPI 1326462185
$9,610.90
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $404 · 2022: $38.75 · 2023: $8,878 · 2024: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,400 · Travel and Lodging: $1,208 · Consulting Fee: $290 · Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,400.00 |
| Travel and Lodging | $1,208.42 |
| Consulting Fee | $290.00 |
| Food and Beverage | $269.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $9,168.40 | 2023-2024 | Optune |
| Nevro Corp. | $124.63 | 2021 | |
| Abbott Laboratories | $69.70 | 2021 | |
| Medtronic, INC. | $63.10 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $46.85 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $36.28 | 2021 | |
| Pfizer INC. | $21.05 | 2021 | |
| Grt US Holding, INC. | $21.03 | 2021 | |
| Abbvie INC. | $17.61 | 2022 | |
| Allergan, INC. | $16.24 | 2021 | |
| Forte Bio-Pharma LLC | $13.61 | 2021 | |
| Lilly USA, LLC | $12.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Kopp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.